Stay updated on Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Sign up to get notified when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the study record history.
    Difference
    0.0%
    Check dated 2026-03-18T23:01:15.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    New site revision entry v3.4.3 added to the history, replacing the previous v3.4.2 entry.
    Difference
    0.0%
    Check dated 2026-03-11T19:57:59.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2026-03-04T16:14:17.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) was added and an old government funding notice was removed; these are site-wide UI updates and do not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T09:27:00.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, with references to cc.nih.gov and opm.gov, and updated the record revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:22:25.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays the study as Active, not recruiting and uses color-coded highlights to show additions and deletions; it also notes the 2026-01-22 revision (v3.4.0) and updates sections such as Contacts/Locations, Study Status, and Study Design.
    Difference
    0.8%
    Check dated 2026-01-28T04:19:51.000Z thumbnail image

Stay in the know with updates to Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.